Shionogi & Co.,Ltd.

塩野義製薬

Industry: Pharmaceutical
Market: Prime
Accounting standards: IFRS
Consolidation basis: Consolidated

Notes

Stock adjustments
Oct 1, 2024 Stock split 1 share → 3 shares

Key metrics

Revenue(million JPY)

Mar 2021

297,177

Mar 2022

335,138

Mar 2023

426,684

Mar 2024

410,073

Mar 2025

438,268

Operating profit(million JPY)

Mar 2021

117,438

Mar 2022

110,312

Mar 2023

149,003

Mar 2024

153,310

Mar 2025

156,603

Operating profit margin(%)

Mar 2021

39.52

Mar 2022

32.92

Mar 2023

34.92

Mar 2024

37.39

Mar 2025

35.73

Profit before tax(million JPY)

Mar 2021

143,018

Mar 2022

126,268

Mar 2023

220,332

Mar 2024

198,283

Mar 2025

200,750

Profit(million JPY)

Mar 2021

111,858

Mar 2022

114,185

Mar 2023

184,965

Mar 2024

162,030

Mar 2025

170,435

Total assets(million JPY)

Mar 2021

998,992

Mar 2022

1,150,601

Mar 2023

1,311,800

Mar 2024

1,416,918

Mar 2025

1,535,349

Cash and cash equivalents(million JPY)

Mar 2021

276,173

Mar 2022

254,420

Mar 2023

309,224

Mar 2024

358,090

Mar 2025

374,795

Cash flows from operating activities(million JPY)

Mar 2021

109,039

Mar 2022

102,068

Mar 2023

177,867

Mar 2024

154,284

Mar 2025

195,460

Cash flows from investing activities(million JPY)

Mar 2021

-5,261

Mar 2022

-96,204

Mar 2023

-48,292

Mar 2024

5,922

Mar 2025

-116,080

Cash flows from financing activities(million JPY)

Mar 2021

-43,891

Mar 2022

-36,615

Mar 2023

-84,123

Mar 2024

-126,853

Mar 2025

-64,908

Return on equity(%)

Mar 2021

13.9

Mar 2022

12.5

Mar 2023

17.8

Mar 2024

13.9

Mar 2025

13.1

Equity ratio(%)

Mar 2021

84.7

Mar 2022

84.8

Mar 2023

83.9

Mar 2024

87.2

Mar 2025

88.7

Earnings per share(JPY per share)

Mar 2021

121.6767

Mar 2022

126.25

Mar 2023

207.1033

Mar 2024

186.17

Mar 2025

200.36

Net assets per share(JPY per share)

Mar 2021

935.5567

Mar 2022

1,078.7367

Mar 2023

1,245.92

Mar 2024

1,452.2167

Mar 2025

1,600.68

Dividend per share(JPY per share)

Mar 2021

Mar 2022

38.3333

Mar 2023

Mar 2024

53.3333

Mar 2025

61.33

Payout ratio(%)

Mar 2021

29.59

Mar 2022

30.36

Mar 2023

21.73

Mar 2024

28.65

Mar 2025

30.61

Disclaimer

The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.

The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.